Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Richard S Ungerleider, MD
Theradex
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
46 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Free University Medical Center
Amsterdam, Netherlands
- Royal Marsden Hospital in Downs Road
Sutton, Surrey, United Kingdom
- Hematology Oncology Associates
Phoenix, Arizona, United States
- Rocky Mountain Cancer Center - Sky Ridge
Lone Tree, Colorado, United States
- Ocala Oncology Center
Ocala, Florida, United States
- Cancer Centers of Florida, Pa
Ocoee, Florida, United States
- John B. Amos Cancer Center
Columbus, Georgia, United States
- Cancer Care & Hematology Specialists of Chicago
Niles, Illinois, United States
- Oncology & Hematology of Central Illinois
Peoria, Illinois, United States
- Blessing Cancer Center
Quincy, Illinois, United States
- Central Indiana Cancer Centers - Indianapolis
Indianapolis, Indiana, United States
- Norton Healthcare - Louisville Oncology
Louisville, Kentucky, United States
- Maryland Oncology Hematology, Pa
Columbia, Maryland, United States
- Alliance Hematology Oncology, Pa - Carroll County Cancer Center
Westminster, Maryland, United States
- West Michigan Cancer Center
Kalamazoo, Michigan, United States
- Minnesota Onc/hem, Pa - Minneapolis
Minneapolis, Minnesota, United States
- University of Mn/division of Hematology, Oncology & Transplantation
Minneapolis, Minnesota, United States
- Missouri Cancer Associates
Columbia, Missouri, United States
- St. Joseph Oncology, Inc.
Saint Joseph, Missouri, United States
- Arch Medical Group - Arch Medical Services, Inc.
St Louis, Missouri, United States
- Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
- New York Oncology Hematology, Pc
Albany, New York, United States
- Suny Upstate Medical Center
Syracuse, New York, United States
- Northwestern Carolina Oncology & Hematology
Hickory, North Carolina, United States
- Raleigh Hematology Oncology Associates
Raleigh, North Carolina, United States
- Willamette Valley Cancer Center
Eugene, Oregon, United States
- Medical Oncology Associates
Kingston, Pennsylvania, United States
- University of Tennessee Medical Center, Knoxville
Knoxville, Tennessee, United States
- Sarah Cannon
Nashville, Tennessee, United States
- Texas Oncology - Amarillo
Amarillo, Texas, United States
- Mamie Mcfaddin Ward Cancer Center
Beaumont, Texas, United States
- Texas Oncology, Pa - Bedford
Bedford, Texas, United States
- Texas Cancer Center at Medical City
Dallas, Texas, United States
- Texas Oncology, P.A. - Dallas
Dallas, Texas, United States
- Texas Oncology, P.A., Sammons Cancer Center
Dallas, Texas, United States
- Texas Oncology, Pa - Fort Worth
Fort Worth, Texas, United States
- West Texas Cancer Center
Odessa, Texas, United States
- Tyler Cancer Center
Tyler, Texas, United States
- Texas Oncology Cancer Care and Research Center
Waco, Texas, United States
- Texas Oncology, Pa - Deke Slayton Cancer Center
Webster, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Nov 2006
- Primary completion
- 1 May 2008
- Completion
- 1 Mar 2009
- Last update posted
- 24 Oct 2019
- Registered enrollment
- 75
- Registry id
- NCT00375193
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.